(Press-News.org) PHILADELPHIA – Two drugs commonly used to treat age-related macular degeneration (AMD) yield similar improvements in vision for patients receiving treatments on a monthly or as-needed basis, according to a study from researchers at the Center for Preventive Ophthalmology and Biostatistics (CPOB) at the Perelman School of Medicine at the University of Pennsylvania. The year-two results of the Comparison of AMD Treatment Trials (CATT) support the findings from the first year of the study that evaluated the effects of Avastin ® (bevacizumab) - the off-label drug most frequently used to treat AMD - and Lucentis® (ranibizumab), a drug approved by the FDA in 2006 for the treatment of AMD. Full long-term results of the CATT, a two-year clinical trial, are published in the current issue of Ophthalmology.
"Regardless of which drug is used, treating AMD requires repeated treatment to prevent loss of vision. These year-two results show that long-term treatment with either Avastin or Lucentis results in similar levels of improvement for these patients suffering from AMD," said Maureen Maguire, PhD, corresponding author on the study and director, CPOB. "We knew these options were available and the drugs were effective in the short-term, but what's become more clear is that the differences between the two drugs over a longer period of time are still almost non-existent – the impact on vision is virtually the same, no matter which drug is used."
Improvement in visual clarity served as the primary outcome measure for the year-two results. AMD is the leading cause of vision loss and blindness in older Americans. In its advanced stages, the wet form of AMD spurs the growth of abnormal blood vessels, which leak fluid and blood into the macula - the central portion of the retina that allows us to look straight ahead and to perceive fine visual detail - and obscure vision. Accumulation of fluid and blood damages the macula causing loss of central vision. Without treatment, most patients with AMD are unable to drive, read, recognize faces or perform tasks that require hand-eye coordination.
Avastin - a drug approved for the treatment of some cancers but not AMD - and Lucentis block growth of abnormal blood vessels and leakage of fluid from the vessels. CATT was originally designed to compare the effectiveness of Avastin and Lucentis as a treatment for AMD. However, in the initial studies for AMD, Lucentis was administered monthly. For the year-two study, researchers focused on determining whether "as-needed" dosing would produce the same long-term visual improvements.
At enrollment, patients were assigned to one of four treatment groups defined by drug (Avastin or Lucentis) and dosing regimen (monthly or as-needed). Patients in the monthly dosing groups received a treatment injection every 28 days. Patients in the as-needed groups received a treatment at baseline and were then examined every 28 days to determine medical need for additional treatment. The original CATT study followed 1185 patients treated at 43 clinical centers in the United States. During year two, researchers examined the continued effects seen in 1107 patients.
"At two years, both drugs proved highly effective regardless of the dosing regimen. Clarity of vision in the patients who received monthly treatments was only slightly better than in those who received treatment as-needed, but all four groups exhibited significant improvement," said Juan Grunwald, MD, professor of Ophthalmology and Principal Investigator of the Photography Reading Center. "Additionally, the lasting improvement these patients experienced is remarkable. After two years, two-thirds of patients had driving vision (20/40 vision or better). In previous studies, only 15 percent of patients retained similar visual acuity.
When tested on a standard eye chart, patients who received monthly treatments experienced an average improvement of about half a line better than those in the as-needed group. Changes in retinal anatomy differed by drug and frequency of treatment, but did not have an impact on vision through 2 years. Though results showed slightly less vision gain with as-needed treatment, researchers say benefits and drawbacks to both regimens should be considered by patients and clinicians.
"Patients who want the small extra advantage afforded with the monthly treatment should also be aware of the additional risks and costs of the monthly injections," explains Maguire. "Those in the as-needed group ultimately required 10 fewer injections over the course of two years and experienced similar visual improvements."
Adverse events indicate development or worsening of a medical condition. They may or may not be causally associated with the clinical trial treatment, but they are always monitored and reported in any clinical trial. The median age of patients in CATT was over 80 years, and a high rate of hospitalizations would be anticipated as a result of chronic or acute medical conditions more common to older populations.
Serious adverse events (SAEs) occurred at a 40 percent rate for patients receiving Avastin and a 32 percent rate for patients receiving Lucentis. Although Avastin had a higher rate of SAEs, they were distributed across many different conditions, most of which were not associated with Avastin when evaluated in cancer clinical trials where the drug was administered at 500 times the dose used for AMD. The number of deaths, heart attacks, and strokes were low and similar for both drugs during the study. Additional data from other clinical trials comparing Avastin and Lucentis may provide further information on the long-term safety profiles of these drugs when used to treat AMD.
###
This study was funded by the National Eye Institute, a part of the National Institutes of Health (5U10EY017828-08). First year results were published in the May 19th, 2011 issue of the New England Journal of Medicine.
Lucentis® and Avastin® are products of Genentech, Inc.
Drs. Maguire and Grunwald have no relevant disclosures.
Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.
The Perelman School of Medicine is currently ranked #2 in U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $479.3 million awarded in the 2011 fiscal year.
The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top 10 hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; and Pennsylvania Hospital — the nation's first hospital, founded in 1751. Penn Medicine also includes additional patient care facilities and services throughout the Philadelphia region.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2011, Penn Medicine provided $854 million to benefit our community.
END
Hans Vogel, a professor in the biological sciences department, is the guest editor of a special issue of the journal Biochemistry and Cell Biology that focuses on lactoferrin, an important iron-binding protein with many health benefits.
"Some people describe this protein as the 'Swiss army knife' of the human host defense system," says Vogel. "We now know that lactoferrin has many functions in innate immunity and that it plays a role in protecting us from bacterial, viral, fungal, and protozoal infections. It can even protect us from some forms of cancer."
Lactoferrin—which ...
There was no change in concentrations of chloride, dissolved solids, or nitrate in groundwater for more than 50 percent of well networks sampled in a new analysis by the USGS that compared samples from 1988-2000 to samples from 2001-2010. For those networks that did have a change, seven times more networks saw increases as opposed to decreases.
The analysis was done by the USGS National Water Quality Assessment Program (NAWQA) to determine if concentrations of these constituents have increased or decreased significantly from the 1990's to the early 2000's nationwide. ...
It's very difficult to kick a star out of the galaxy.
In fact, the primary mechanism that astronomers have come up with that can give a star the two-million-plus mile-per-hour kick it takes requires a close encounter with the supermassive black hole at the galaxy's core.
So far astronomers have found 16 of these "hypervelocity" stars. Although they are traveling fast enough to eventually escape the galaxy's gravitational grasp, they have been discovered while they are still inside the galaxy.
Now, Vanderbilt astronomers report in the May issue of the Astronomical ...
Robert Stanek, bestselling author of over 150 published books, has a passion to help other independently published authors reach their goals. Stanek lives in Washington State, but his reach is international via the internet. Over the past 11 years he has developed several venues to help promote and market indie authors giving them more online exposure and visibility. He works diligently to offer ways in which to showcase new authors and books. One example is his blog readindies.blogspot.com (http://readindies.blogspot.com/).
Stanek started his writing career as a technical ...
ThePetCrib.com (http://www.thepetcrib.com/), a leading online store for upscale dog products and cat products announced today they will begin promotion one pet product a month as a special way to highlight their vendors products. The pet product of the month promotion will begin in May of 2012.
"We really work hard to represent vendors and pet products that are high quality and unique," said Bryan Cochran, owner of ThePetCrib.com. "The pet products we sell represent some of the best in the pet products industry. This is an opportunity for us to showcase ...
"Love thy neighbor" is preached from many a pulpit. But new research from the University of California, Berkeley, suggests that the highly religious are less motivated by compassion when helping a stranger than are atheists, agnostics and less religious people.
In three experiments, social scientists found that compassion consistently drove less religious people to be more generous. For highly religious people, however, compassion was largely unrelated to how generous they were, according to the findings which are published in the July issue of the journal Social Psychological ...
COLUMBIA, Mo. – As the United States grapples with health care reform, much attention has focused on the importance of preventative health care. Now, a researcher at the University of Missouri has developed a system that could help public health care organizations determine the best method of allocating resources by prioritizing health risk factors and conditions – in some cases before these conditions become major health problems.
"Every state, county and community has different trends and needs in public health," said Eduardo Simoes, chair of the Department of Health ...
Folsom fitness expert and owner of Superwomen Boot Camp (SWBC), Val Fujii is proud to announce that he has added a 5pm class to the Folsom SWBC afternoon lineup.
In addition, the days for afternoon classes have changed effective this week. Afternoon classes are now held on Tuesdays, Wednesdays and Thursdays at 4pm, 5pm and 6pm. These classes are in addition to the boot camp's morning offerings on Mondays, Wednesdays and Fridays at 6am and 7am.
According to Fujii, Superwomen Boot Camp is not your typical 'hard core' boot camp - no one is going to yell in your face or ...
The problem with clutter is, well, the clutter. Being unable to part with things can prolong some spring cleanings into a summer project. And nobody wants to be stuck inside decluttering once the weather gets nice.
Certified Professional Organizer Wendy Arundel, owner and manager of The Mudroom, a Wellesley-based company serving Greater Boston, suggests a more practical, less emotional approach to a spring cleaning/decluttering.
âEURœYour focus really needs to be on how decluttering your space will improve your life and your living environment. You might even want ...
Patients find "cloud" technology a faster, more efficient way to store and distribute their medical images than current options, according to the preliminary findings of an image sharing project led by The Mount Sinai Medical Center in conjunction with four other academic medical institutions. The Phase I results of the Radiological Society of North America (RSNA) Image Share project are being presented today at the American Roentgen Ray Society Annual Meeting in Vancouver, Canada.
Mount Sinai was the first site to go live in August 2011 and currently has about 190 patients ...
